Pharmaceutical research · 2026
Syn-Anti Conformational Equilibrium of Indomethacin: A Combined NOESY and Quantum Chemical Study.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kovalev Aleksey, Belov Konstantin, Barrera Yoshio, Kaya Savaş, Khodov Ilya
Аннотация
PURPOSE: To elucidate the conformational equilibrium of Indomethacin in solution and to establish its relationship with solvent environment and solid-state polymorphism.
METHODS: A combined experimental-computational approach was employed. One- and two-dimensional NOESY NMR spectroscopy were used to quantify cross-relaxation rates and derive conformation-sensitive internuclear distances in DMSO-d6 and CDCl3. Conformer populations were determined using the initial rate approximation and isolated spin-pair approximation. Quantum-chemical calculations based on Density Functional Theory (B3LYP-D3(BJ)/def2-TZVP, SMD solvation model) were performed to evaluate conformer energetics and solvent effects.
RESULTS: Two conformer families, syn- and anti-, were identified as key structural motifs governing indomethacin behavior. InDMSO-d6, the syn-conformer dominates (80.8%), whereas in CDCl3 the equilibrium shifts toward nearly equal populations (51.5% syn, 48.5% anti), revealing a strong solvent-dependent effect. Experimentally derived NOESY distances showed excellent agreement with computed geometries. DFT calculations confirmed the energetic preference of syn-type conformers while demonstrating significant solvent-induced changes in relative stability. Importantly, a direct correlation between solution-phase conformational equilibrium and known polymorphic forms was established.
CONCLUSION: This study demonstrates that solvent-controlled conformational equilibria play a probable role in determining the solid-state forms of indomethacin. The integrated NOESY-DFT methodology provides a robust and quantitative framework for conformational analysis and offers a predictive tool for rational design and optimization of pharmaceutical solid forms.
METHODS: A combined experimental-computational approach was employed. One- and two-dimensional NOESY NMR spectroscopy were used to quantify cross-relaxation rates and derive conformation-sensitive internuclear distances in DMSO-d6 and CDCl3. Conformer populations were determined using the initial rate approximation and isolated spin-pair approximation. Quantum-chemical calculations based on Density Functional Theory (B3LYP-D3(BJ)/def2-TZVP, SMD solvation model) were performed to evaluate conformer energetics and solvent effects.
RESULTS: Two conformer families, syn- and anti-, were identified as key structural motifs governing indomethacin behavior. InDMSO-d6, the syn-conformer dominates (80.8%), whereas in CDCl3 the equilibrium shifts toward nearly equal populations (51.5% syn, 48.5% anti), revealing a strong solvent-dependent effect. Experimentally derived NOESY distances showed excellent agreement with computed geometries. DFT calculations confirmed the energetic preference of syn-type conformers while demonstrating significant solvent-induced changes in relative stability. Importantly, a direct correlation between solution-phase conformational equilibrium and known polymorphic forms was established.
CONCLUSION: This study demonstrates that solvent-controlled conformational equilibria play a probable role in determining the solid-state forms of indomethacin. The integrated NOESY-DFT methodology provides a robust and quantitative framework for conformational analysis and offers a predictive tool for rational design and optimization of pharmaceutical solid forms.